Research / XYL / Fundamental state Inspectable configuration
State dimensions Filing 0001524472-25-000046 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
87.08% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.48% · OPTIONAL · VALID
Operating cash generation 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.87% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
7.79% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
45.63% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.93% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.73% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.29% · OPTIONAL · VALID
SBC intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.53% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 49 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 8/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 87.31%
Current 87.08%
Delta -0.23% Capex Intensity Decreased
Previous 4.26%
Current 3.48%
Delta -0.78% Cash Generation Increased
Previous 13.26%
Current 15.87%
Delta 2.62% Growth Increased
Previous 6.09%
Current 7.79%
Delta 1.71% Inventory Pressure Decreased
Previous 46.54%
Current 45.63%
Delta -0.91% Margin Increased
Previous 38.77%
Current 38.93%
Delta 0.17% Profitability Increased
Previous 13.26%
Current 14.73%
Delta 1.47% R And D Intensity Decreased
Previous 2.52%
Current 2.29%
Delta -0.23% Sbc Intensity Decreased
Previous 0.56%
Current 0.53%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.